Suchergebnisse - "Monin, Malte B"

PubPharm (9)

1

Antiviral treatment of COVID-19 : which role can clinical parameters play in therapy evaluation?

enthalten in: Infection | 2023

von Hübner, Y. | Spuck, N. | Berger, M. | +10

2

Early combination therapy of COVID-19 in high-risk patients

enthalten in: Infection | 2023

von Orth, H. | Flasshove, C. | Berger, M. | +26

3

Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma : A Forgotten, Vulnerable Group of Patients

enthalten in: Liver cancer | 2023

von Monin, M. | Baier, L. | Gorny, J. | +12

4

Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?

enthalten in: Infection | 2023

von Hübner, Y. | Spuck, N. | Berger, M. | +10

5

SARS-CoV-2 PrEP complicates antibody testing after vaccination : a call for awareness

enthalten in: Annals of hematology | 2022

von Monin, M. | Marx, B. | Meffert, L. | +5

6

SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness

enthalten in: Annals of hematology | 2022

von Monin, M. | Marx, B. | Meffert, L. | +5

7

SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness

enthalten in: Annals of hematology | 2022

von Monin, M. | Marx, B. | Meffert, L. | +5

8

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

enthalten in: The Journal of infectious diseases | 2022

von Rieke, G. | van Bremen, K. | Bischoff, J. | +15

CommentIn: J Infect Dis. 2022 May 16;225(10):1685-1687. - PMID 35323974

9

Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19

enthalten in: Immunity | 2021

von Krämer, B. | Knoll, R. | Bonaguro, L. | +146

CommentIn: J Allergy Clin Immunol. 2022 Apr;149(4):1223-1224. - PMID 35051507

1
[1]